AGRENVEC SL is a private biotechnology company that produces high-quality recombinant proteins using plants as biofactories. Founded in 2002, and a pioneer in plant-based manufacturing, they have developed a broad portfolio of recombinant human proteins for skin care, diagnostics, research and biotechnological applications. Its R&D and manufacturing headquarters are located in the Tres Cantos Technology Park. Expanded manufacturing capacity is already operational at its state-of-the-art facility to produce hundreds of grams of recombinant protein each year.
- ACTIVITY: Biotechnology: production of recombinant proteins in plants.
- LOCATION: c/Santiago Grisolía, Parque Tecnológico, 28760 Tres Cantos, Madrid.
- CONSTITUTION DATE: 05/11/2001.
- CATEGORY: SME.
- CONTACT: isabel.bronchalo@agrenvec.es / www.agrenvec.es
- NUMBER OF EMPLOYEES: 22.
- INCOME: €1.5 M.
- GENERAL DESCRIPTION: Private biotechnology company produces high-quality recombinant proteins using plants as biofactories. Founded in 2002, and a pioneer in plant-based manufacturing, they have developed a broad portfolio of recombinant human proteins for skin care, diagnostics, research and biotechnological applications. Its R&D and manufacturing headquarters are located in the Tres Cantos Technology Park. Expanded manufacturing capacity is already operational at its state-of-the-art facility to produce hundreds of grams of recombinant protein each year.
- BUSINESS LINES:
- Production of human proteins for the dermocosmetic market.
- Production of proteins as reagents for use in diagnosis.
- Production of growth factors for cultured meat culture media.
- INFRASTRUCTURE: 300 m2 laboratory and 2,000 m2 plant production plant.
TECHNOLOGICAL SUPPLY/DEMAND:
- Offer: production of customized recombinant proteins.
- Demand: proteomics services, cell culture, expression systems in plants.
They have not requested public financing in the last eight years, all developments have been financed with their own resources.
English 
Spanish